Depletion of the actin bundling protein SM22/transgelin increases actin dynamics and enhances the tumourigenic phenotypes of cells

BMC Cell Biology

Volumn 13, Issue , 2012, Pages

  Thompson, Oliver ^a   Moghraby, Jeelan S ^a,b   Ayscough, Kathryn R ^a   Winder, Steve J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b KING ABDULLAH INTERNATIONAL MEDICAL RESEARCH CENTER   (Saudi Arabia)

Author keywords

Cell motility; Invasion; Podosomes; Reactive oxygen species; Tumour suppressor

Indexed keywords

REACTIVE OXYGEN METABOLITE; TRANSGELIN; ACTIN; ACTIN BINDING PROTEIN; COLLAGEN; LAMININ; MATRIGEL; MUSCLE PROTEIN; PROTEOGLYCAN; SMALL INTERFERING RNA;

ACTIN POLYMERIZATION; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL ORGANELLE; CELL STRESS; CELL SURVIVAL; CHEMOTAXIS; CONTROLLED STUDY; FIBROBLAST; PODOSOME; SERUM STARVATION STRESS; CANCER INVASION; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CELL TRANSFORMATION; CYTOLOGY; DRUG COMBINATION; GENETICS; HUMAN; METABOLISM; PHENOTYPE; PHYSIOLOGY; TUMOR CELL LINE;

ACTINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; FIBROBLASTS; HUMANS; LAMININ; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; NEOPLASM INVASIVENESS; PHENOTYPE; PROTEOGLYCANS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING;

EID: 84855878761     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-13-1     Document Type: Article

References (45)

1. Lees-Miller JP, Heeley DH, Smillie LB, Kay CM. Isolation and characterization of an abundant and novel 22-kDa protein (SM22) from chicken gizzard smooth muscle. J Biol Chem 1987, 262:2988-2993.
2. Shapland C, Hsuan JJ, Totty NF, Lawson D. Purification and Properties Of Transgelin - a Transformation and Shape Change Sensitive Actin-Gelling Protein. J Cell Biol 1993, 121(5):1065-1073. 10.1083/jcb.121.5.1065, 2119678, 8501116.
3. Pearlstone JR, Weber M, Lees-Miller JP, Carpenter MR, Smillie LB. Amino acid sequence of chicken gizzard smooth muscle SM22 alpha. J Biol Chem 1987, 262(13):5985-5991.
4. Lawson D, Harrison M, Shapland C. Fibroblast transgelin and smooth muscle SM22 alpha are the same protein, the expression of which is down-regulated in many cell lines. Cell Motility and the Cytoskeleton 1997, 38(3):250-257. 10.1002/(SICI)1097-0169(1997)38:3<250::AID-CM3>3.0.CO;2-9, 9384215.
5. Assinder SJ, Stanton J-AL, Prasad PD. Transgelin: An actin-binding protein and tumour suppressor. Int J Biochem Cell Biol 2009, 41(3):482-486. 10.1016/j.biocel.2008.02.011, 18378184.
6. Gimona M, Djinovic-Carugo K, Kranewitter W, Winder S. Functional plasticity of CH domains. FEBS Lett 2002, 513:98-106. 10.1016/S0014-5793(01)03240-9, 11911887.
7. Kranewitter WJ, Ylanne J, Gimona M. UNC-87 is an actin bundling protein. J Biol Chem 2001, 276:6306-6312. 10.1074/jbc.M009561200, 11096113.
8. Gimona M, Winder SJ. Single calponin homology domains are not actin binding domains. Curr Biol 1998, 8:R674-675.
9. Rozenblum GT, Gimona M. Calponins: Adaptable modular regulators of the actin cytoskeleton. Int J Biochem Cell Biol 2008, 40(10):1990-1995. 10.1016/j.biocel.2007.07.010, 17768079.
10. Ayme-Southgate A, Lasko P, French C, Pardue ML. Characterization of the gene for mp20: a Drosophila muscle protein that is not found in asynchronous oscillatory flight muscle. J Cell Biol 1989, 108(2):521-531. 10.1083/jcb.108.2.521, 2115408, 2537318.
11. Goodman A, Goode BL, Matsudaira P, Fink GR. The Saccharomyces cerevisiae Calponin/Transgelin Homolog Scp1 Functions with Fimbrin to Regulate Stability and Organization of the Actin Cytoskeleton. Mol Biol Cell 2003, 14:2617-2629. 10.1091/mbc.E03-01-0028, 165663, 12857851.
12. Winder SJ, Jess T, Ayscough KR. SCP1 encodes an actin bundling protein in yeast. Biochem J 2003, 375:287-295. 10.1042/BJ20030796, 1223692, 12868959.
13. Gourlay CW, Carpp LN, Timpson P, Winder SJ, Ayscough KR. A Role for the Actin Cytoskeleton in Cell Death and Ageing in Yeast. J Cell Biol 2004, 164:803-809. 10.1083/jcb.200310148, 2172293, 15024029.
14. Thweatt R, Lumpkin CK, Goldstein S. A novel gene encoding a smooth muscle protein is overexpressed in senescent human fibroblasts. Biochem Biophys Res Commun 1992, 187:1-7. 10.1016/S0006-291X(05)81449-4, 1520290.
15. Simoes DDM, Gonos ES. Alterations of gene expression during in vitro ageing: The mammalian fibroblast model. Current Science 1998, 74(10):884-886.
16. Dumont P, Burton M, Chen QM, Gonos ES, Frippiat C, Mazarati J-B, Eliaers F, Remacle J, Toussaint O. Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast. Free Rad Biol Med 2000, 28:361-373. 10.1016/S0891-5849(99)00249-X, 10699747.
17. Han M, Dong L-H, Zheng B, Shi J-H, Wen J-K, Cheng Y. Smooth muscle 22 alpha maintains the differentiated phenotype of vascular smooth muscle cells by inducing filamentous actin bundling. Life Sci 2009, 84(13):394-401. 10.1016/j.lfs.2008.11.017, 19073196.
18. Gimona M, Buccione R. Adhesions that mediate invasion. Int J Biochem Cell Biol 2006, 38(11):1875. 10.1016/j.biocel.2006.05.003, 16790362.
19. Kaverina I, Stradal TEB, Gimona M. Podosome formation in cultured A7r5 vascular smooth muscle cells requires Arp2/3-dependent de-novo actin polymerization at discrete microdomains. J Cell Sci 2003, 116(24):4915-4924. 10.1242/jcs.00818, 14625385.
20. Jin L, Hastings N, Blackman B, Somlyo A. Mechanical properties of the extracellular matrix alter expression of smooth muscle protein LPP and its partner palladin; relationship to early atherosclerosis and vascular injury. J Muscle Res Cell Motil 2009, 30(1):41-55. 10.1007/s10974-009-9173-1, 2852132, 19205907.
21. Lener T, Burgstaller G, Crimaldi L, Lach S, Gimona M. Matrix-degrading podosomes in smooth muscle cells. Eur J Cell Biol 2006, 85:183-189. 10.1016/j.ejcb.2005.08.001, 16546560.
22. Thompson O, Kleino I, Crimaldi L, Gimona M, Saksela K, Winder SJ. Dystroglycan, Tks5 and Src mediated assembly of podosomes in myoblasts. PLoS One 2008, 3:e3638. 10.1371/journal.pone.0003638, 2572840, 18982058.
23. Katsumi S, Shian-Ying S, Hiroyuki K, Rebecca SA, Masato F, Akinobu G, Haiyen EZ, Leland WKC. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells. Prostate 2007, 67(7):722-731. 10.1002/pros.20565, 17342749.
24. Lee S, Kim J, Kim T, Kim B, Lee M-S, Yoo Y. Serum deprivation-induced reactive oxygen species production is mediated by Romo1. Apoptosis 2010, 15(2):204-218. 10.1007/s10495-009-0411-1, 19904609.
25. Yamamura H, Yoshikawa H, Tatsuta M, Akedo H, Takahashi K. Expression of the smooth muscle calponin gene in human osteosarcoma and its possible association with prognosis. Int J Cancer 1998, 79(3):245-250. 10.1002/(SICI)1097-0215(19980619)79:3<245::AID-IJC6>3.0.CO;2-P, 9645345.
26. Desai B, Ma T, Chellaiah MA. Invadopodia and Matrix Degradation, a New Property of Prostate Cancer Cells during Migration and Invasion. J Biol Chem 2008, 283(20):13856-13866. 10.1074/jbc.M709401200, 2376228, 18337256.
27. Prasad P, Stanton J-A, Assinder S. Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer. Cell Tissue Res 2010, 339(2):337-347. 10.1007/s00441-009-0902-y, 20012321.
28. Gheorghe DM, Aghamohammadzadeh S, Rooij IIS-D, Allwood EG, Winder SJ, Ayscough KR. Interactions between the Yeast SM22 Homologue Scp1 and Actin Demonstrate the Importance of Actin Bundling in Endocytosis. J Biol Chem 2008, 283(22):15037-15046. 10.1074/jbc.M710332200, 2397485,2397485, 18400761.
29. Lener T, Burgstaller G, Gimona M. The role of calponin in the gene profile of metastatic cells: inhibition of metastatic cell motility by multiple calponin repeats. FEBS Lett 2004, 556(1-3):221-226. 10.1016/S0014-5793(03)01401-7, 14706854.
30. Yamashiro S, Gimona M, Ono S. UNC-87, a calponin-related protein in C. elegans, antagonizes ADF/cofilin-mediated actin filament dynamics. J Cell Sci 2007, 120(17):3022-3033. 10.1242/jcs.013516, 2365702, 17684058.
31. Lin Y, Buckhaults PJ, Lee JR, Xiong H, Farrell C, Podolsky RH, Schade RR, Dynan WS. Association of the actin-binding protein transgelin with lymph node metastasis in human colorectal cancer. Neoplasia 2009, 11:864-873. 2735797, 19724680.
32. Li N, Zhang J, Liang Y, Shao J, Peng F, Sun M, Xu N, Li X, Wang R, Liu S, et al. A controversial tumor marker: is SM22 a proper biomarker for gastric cancer cells?. J Proteome Res 2007, 6:3304-3312. 10.1021/pr0702363, 17629319.
33. Glen A, Evans CA, Gan CS, Cross SS, Hamdy FC, Gibbins J, Lippitt J, Eaton CL, Noirel J, Wright PC, et al. Eight-plex iTRAQ analysis of variant metastatic human prostate cancer cells identifies candidate biomarkers of progression: An exploratory study. Prostate 2010, 70(12):1313-1332.
34. Lee E-K, Han G-Y, Park HW, Song Y-J, Kim C-W. Transgelin Promotes Migration and Invasion of Cancer Stem Cells. J Proteome Res 2010, 9(10):5108-5117. 10.1021/pr100378z, 20707403.
35. Hazan RB, Qiao RUI, Keren R, Badano I, Suyama K. Cadherin Switch in Tumor Progression. Ann N Y Acad Sci 2004, 1014(1):155-163. 10.1196/annals.1294.016, 15153430.
36. Nair RR, Solway J, Boyd DD. Expression Cloning Identifies Transgelin (SM22) as a Novel Repressor of 92-kDa Type IV Collagenase (MMP-9) Expression. J Biol Chem 2006, 281(36):26424-26436. 10.1074/jbc.M602703200, 16835221.
37. Shen J, Yang M, Ju D, Jiang H, Zheng J-P, Xu Z, Li L. Disruption of SM22 Promotes Inflammation After Artery Injury via Nuclear Factor {kappa}B Activation. Circ Res 2010, 106(8):1351-1362. 10.1161/CIRCRESAHA.109.213900, 2896867, 20224039.
38. Frippiat C, Chen QM, Zdanov S, Magalhaes J-P, Remacle J, Toussaint O. Subcytotoxic H2O2 Stress Triggers a Release of Transforming Growth Factor-beta 1, Which Induces Biomarkers of Cellular Senescence of Human Diploid Fibroblasts. J Biol Chem 2001, 276(4):2531-2537. 10.1074/jbc.M006809200, 11060295.
39. Bonello T, Stehn J, Gunning P. New approaches to targeting the actin cytoskeleton for chemotherapy. Future Med Chem 2009, 1:1311-1331. 10.4155/fmc.09.99, 21426105.
40. Rao J, Li N. Microfilament actin remodeling as a potential target for cancer drug development. Curr Cancer Drug Targets 2004, 4:345-354. 10.2174/1568009043332998, 15180500.
41. Thompson O, Moore CJ, Hussain S-A, Kleino I, Peckham M, Hohenester E, Ayscough KR, Saksela K, Winder SJ. Modulation of cell spreading and cell-substrate adhesion dynamics by dystroglycan. J Cell Sci 2010, 123:118-127. 10.1242/jcs.047902, 2794713, 20016072.
42. Mori K, Muto Y, Kokuzawa J, Yoshioka T, Yoshimura S, Iwama T, Okano Y, Sakai N. Neuronal protein NP25 interacts with F-actin. Neurosci Res 2004, 48(4):439-446. 10.1016/j.neures.2003.12.012, 15041197.
43. Batchelor CL, Higginson JR, Chen Y-J, Vanni C, Eva A, Winder SJ. Recruitment of Dbl by ezrin and dystroglycan drives membrane proximal Cdc42 activation and filopodia formation. Cell Cycle 2007, 6:353-363. 10.4161/cc.6.3.3819, 17297291.
44. Bryant RJ, Winder SJ, Cross SS, Hamdy FC, Cunliffe VT. The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells. Prostate 2008, 68(3):255-263. 10.1002/pros.20705, 18095286.
45. Higginson JR, Thompson O, Winder SJ. Targeting of dystroglycan to the cleavage furrow and midbody in cytokinesis. Int J Biochem Cell Biol 2008, 40:892-900. 10.1016/j.biocel.2007.10.019, 18054267.